Financial Services Guide
  1. Home
  2. Financial Services Guide
VolitionRx Limited (NYSE: VNRX): Validated th...
By ACE Investors / 15 Jan 2026
Read More
LeMaitre Vascular, Inc. (NASDAQ: LMAT) - a pr...
By ACE Investors / 14 Jan 2026
Read More
EBR Systems Inc. (ASX: EBR): De-risked regula...
By ACE Investors / 13 Jan 2026
Read More
Exact Sciences Corp. (NASDAQ: EXAS) – rerat...
By ACE Investors / 12 Jan 2026
Read More
CSL Limited (ASX: CSL): Building a more focus...
By ACE Investors / 08 Jan 2026
Read More
Imugene Limited (ASX: IMU) - a clinical-stage...
By ACE Investors / 06 Jan 2026
Read More
Actinogen Medical (ASX: ACW) - a late-stage C...
By ACE Investors / 24 Dec 2025
Read More
Senti Biosciences, Inc. (NASDAQ: SNTI) – a ...
By ACE Investors / 22 Dec 2025
Read More
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) - a c...
By ACE Investors / 19 Dec 2025
Read More
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) – ...
By ACE Investors / 18 Dec 2025
Read More
Adicet Bio, Inc. (NASDAQ: ACET) - a clinical-...
By ACE Investors / 18 Dec 2025
Read More
U.S. Physical Therapy, Inc. (NYSE: USPH): Rea...
By ACE Investors / 17 Dec 2025
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors